Combining conventional therapy with immunotherapy: A risky business?
Coosemans A, Vankerckhoven A, Baert T, Boon L, Ruts H, Riva M, Blagden S, Delforge M, Concin N, Mirza MR, Ledermann JA, du Bois A, Vergote I.
Coosemans A, et al. Among authors: riva m.
Eur J Cancer. 2019 May;113:41-44. doi: 10.1016/j.ejca.2019.02.014. Epub 2019 Apr 6.
Eur J Cancer. 2019.
PMID: 30965214